Nanosonics is a medical technology company with its flagship product being the trophon EPR system. The trophon system disinfects ultrasound probes with rapid efficiency. Ultrasound probes are vitally important to hospitals and medical clinics because they are the things that radiographers and doctors use to see what’s going on inside the patient’s body. Nanosonics claims to reduce error and increase efficiency — saving clinics time and making them money.
Did we miss the boat on Premier Investments Ltd (ASX:PMV)?
Here’s why I think it’s worth looking at shares of Appen Ltd (ASX: APX), Nanosonics Ltd. (ASX: NAN) and Nearmap Ltd (ASX: NEA).
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 1.00% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 0.43% at lunch.
The Nanosonics Ltd. (ASX:NAN) share price is up around 25% in response to the release of its FY19 report to investors.
Clinuvel Pharmaceuticals Limited (ASX:CUV) shares are up nearly 90% year-to-date and 200% over the last 12 months. Is it too late to buy?
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently up 1.02% at lunch.
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is currently down 0.27% at lunch.
Nanosonics Limited (ASX: NAN) shares are up 66% year-to-date. Is it too late to invest, or could the shares keep going higher?
